Yseop’s latest whitepaper, "Harness the Power of Generative AI in Pharma," is now live! Discover how Generative AI is transforming drug discovery, accelerating clinical trials, and streamlining regulatory submissions. This comprehensive guide explores the significant opportunities for GenAI in BioPharma: ?? In-depth use cases for automation in clinical trials ?? The potential of AI to reduce costs and improve efficiency ?? Best practices for AI implementation and change management Download now: https://bit.ly/47hQeAB #GenerativeAI #Pharma #LifeSciences #DrugDevelopment #Innovation
Yseop
软件开发
New York，NY 10,031 位关注者
Yseop Copilot is the world’s most trusted digital colleague for scientific writing using Generative AI
关于我们
Yseop is the leader in Generative AI for regulated industries, changing the way content automation solutions are delivered with a human-centric, AI platform. Yseop is reimagining the future of scientific writing to get medicine into the hands of those who need it faster. With a suite of industry-specific applications and cutting-edge hybrid Natural Language Generation (NLG) technology that blends symbolic, machine learning, and LLM techniques, Yseop ensures that even the most demanding content automation tasks are met with ease, scalability and application security across the entire enterprise. As the world’s leading content automation solution for biopharmaceuticals, Yseop Copilot is a digital colleague that empowers scientific writers and addresses the unique requirements of regulated industries. Blending the power of large language models with customer data, Yseop Copilot delivers trusted and auditable content automation solutions in a closed, secure environment.
- 网站
-
https://yseop.com
Yseop的外部链接
- 所属行业
- 软件开发
- 规模
- 51-200 人
- 总部
- New York，NY
- 类型
- 私人持股
- 创立
- 2007
- 领域
- artificial intelligence、natural language generation、automated reporting、business intelligence、Report Generation、Reporting、NLG、AI、virtual assistant、generative AI、GenAI和LLM
地点
Yseop员工
动态
-
Aujourd’hui, nous avons eu le plaisir de partager notre expérience à l’AWS GenAI Day à STATION F, Paris ! Cet événement a été une formidable opportunité d’échanger avec les leaders du secteur sur l’impact révolutionnaire de l’IA générative dans le SaaS et bien au-delà. La communauté fran?aise de l’IA générative était au rendez-vous, témoignant d’un véritable engouement pour cette technologie qui transforme les modèles d’innovation. Cet événement a mis en lumière l’innovation portée par la #GenerativeAI, ouvrant de nouvelles perspectives et permettant de rester à la pointe de la technologie. Un grand merci à Amazon Web Services (AWS) pour l’organisation ainsi qu’aux intervenants inspirants! Pour en savoir plus, contactez nous dès maintenant: https://bit.ly/3Sudx4J #AWS #IAgénérative #Innovation #GenAI #Bedrock #Sagemaker #LLM #SaaS Pierre-Louis Durel Julien Groues Stephan Hadinger Dimitri Le Parc
-
Tomorrow, join us at the 32nd BVMA Symposium in Munich. Our CEO, Emmanuel Walckenaer, will be sharing expert insights on how the top pharma companies are leveraging GenAI at scale to accelerate their regulatory submission timelines. ??Don’t miss this opportunity to explore the future of #GenerativeAI in #MedicalWriting, #ClinicalResearch, and #LifeSciencesInnovation. ??Register here: https://lnkd.in/dpJ5EZB
-
-
In industries where compliance, efficiency, and speed are paramount, deciding between building in-house or adopting an external GenAI solution is pivotal. Our latest blog explores how an external platform can enhance scalability, ensure compliance, and free your team to focus on innovation and growth. ?? Learn more: https://lnkd.in/ehGJcd7W #GenerativeAI #Innovation #Biopharma #Pharma
-
-
This weekend, the Yseop team joined 14,000 participants in the 'Course des Lumières,' a night of running and walking along Paris’s iconic landmarks to support cancer and diabetes research. The event radiated hope and determination, and we are proud to have contributed to raising awareness for these vital causes. A heartfelt thank you to everyone who participated and made this evening so special. Together, we’re making strides toward a healthier future. #CourseDesLumières #Hope #MakingADifference
-
-
Join us at Station F in Paris on Monday, November 25th, for an exciting deep dive into the world of generative AI, in partnership with Amazon Web Services (AWS). Don’t miss Pierre-Louis Durel's keynote at 10:30am, where he’ll discuss how Yseop is revolutionizing automated text generation for the pharmaceutical industry using advanced AI technologies. Want more details? Learn more: https://lnkd.in/guDYD3y5 #AWS #GenerativeAI #AI #Innovation #PharmaTech Dimitri Le Parc Alejandro A.
-
-
Discover how Generative AI is revolutionizing BioPharma—streamlining clinical trials, cutting costs, and accelerating drug development. Our latest whitepaper, Harness the Power of Generative AI in Pharma, reveals: ?? Game-changing automation use cases ?? How to reduce regulatory complexity ?? Steps to integrate AI effectively Ready to future-proof your workflows? ?? Download now: https://bit.ly/47hQeAB #GenerativeAI #PharmaInnovation #AIinHealthcare
-
-
The future of medical writing is evolving, and Yseop is at the forefront. Join us at the 32nd Bundesverband Medizinischer Auftragsinstitute e.V. (BVMA) Symposium on November 22 in Munich, where our CEO, Emmanuel Walckenaer, will discuss how Generative AI is advancing efficiency and accuracy in life sciences documentation. Sign up for the event here: https://lnkd.in/dpJ5EZB #GenerativeAI #MedicalWriting #ClinicalResearch
There is no doubt that advanced AI technologies are reimagining the future of medical writing. Until now, medical writers have been faced with inefficient, monotonous processes and have been looking for a solution to save time and ensure accuracy. We will learn that this way of working is a thing of the past in the presentation by Emmanuel Walckenaer from Yseop. Stay curious and be curious. #clinicalresearch #klinischeforschung #standardvertragsklauseln #medizinforschungsgesetz #wefeelresponsible
-
-
In highly regulated industries, the 'Build vs. Buy' decision affects not only resources and compliance but also time to market, making it a high-stakes choice. For processes like regulatory document authoring, purchasing an AI solution enables quick implementation, compliance-ready capabilities and scalability, freeing companies to focus on advancing drug development. Curious to see which path may be best for your organization? Dive into our new blog to explore why an external GenAI platform could be the strategic advantage you need. https://lnkd.in/ehGJcd7W #generativeai #genai #iagenerative #innovation #ai #biopharma #pharma
-
-
Retrouvez Yseop à Station F le lundi 25 novembre pour une immersion au c?ur de l’IA générative, en partenariat avec Amazon Web Services (AWS). Pierre-Louis Durel prendra la parole lors d'une keynote dès 10h30. Découvrez comment #Yseop révolutionne la génération automatique de textes dans l’industrie pharmaceutique grace à des solutions d’IA de pointe. Pour planifier un rendez-vous avec notre équipe ou pour plus d'informations: https://lnkd.in/guDYD3y5 #AWS #GenAI #GenerativeAI #IA #IAGénérative #Innovation
SAVE THE DATE:?AWS GenAI Day??? Lundi 25 novembre : Immersion dans l’IA générative à Station F avec AWS?? Le matin, une?Keynote exceptionnelle?présentée par Julien Groues, VP France & Europe South AWS, Stephan Hadinger, CTO France AWS, Dr. Ségolène Dessertine-Panhard, Tech Lead Responsible AI AWS, Roxanne Varza, Directrice STATION F,?avec des témoignages de clients tels que Bassem ASSEH, Directeur Commercial Hugging Face, Guillaume Duvaux, Director Sales South Europe poolside, Pierre-Louis Durel, VP corporate Development Yseop et plus encore.??? Au programme de cette journée : - Sessions Tech, Industry, et Startups - Stands de startups GenAI innovantes - Démonstrations AWS - Stand "Ask an Expert" pour venir poser vos questions Tech et Business Inscrivez-vous dès maintenant :?https://lnkd.in/ev6kTeCQ — En partenariat avec Amazon et Amazon Web Services (AWS)